Christopher R. Cline – Insider Trading Activity | DataHeimdall

Christopher R. Cline

CHIEF FINANCIAL OFFICER at Travere Therapeutics, Inc.

CIK: 1943192

9

Total trades

2

Buys

6

Sells

May 4, 2026

Last trade

Date	Stock	Type	Shares	Value	Src
May 4, 2026	TVTXTravere Therapeutics, Inc.	Sell	2,181	$102K
May 4, 2026	TVTXTravere Therapeutics, Inc.	Sell	310	$14K
May 4, 2026	TVTXTravere Therapeutics, Inc.	Option	4,250	–
May 4, 2026	TVTXTravere Therapeutics, Inc.	Buy	8,500	–
Apr 13, 2026	TVTXTravere Therapeutics, Inc.	Sell	65	$2K
Apr 13, 2026	TVTXTravere Therapeutics, Inc.	Buy	14,000	–
Apr 13, 2026	TVTXTravere Therapeutics, Inc.	Sell	9	$369.63
Apr 13, 2026	TVTXTravere Therapeutics, Inc.	Sell	7,239	$304K
Apr 13, 2026	TVTXTravere Therapeutics, Inc.	Sell	1,014	$43K